ClinicalTrials.Veeva

Menu

Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial

D

Dynasplint Systems.

Status

Completed

Conditions

Hallux Limitus

Treatments

Device: Metatarsophalangeal Extension Dynasplint System
Other: Standard of Care

Study type

Interventional

Funder types

Industry

Identifiers

NCT00717691
2008.003

Details and patient eligibility

About

The purpose of this study is to regain range of motion of the great toe with dynamic splinting which will help reduce great toe's pain and swelling.

Full description

Determine the efficacy of dynamic splinting in treating patients with hallux limitus, in a randomized, controlled trial.

Enrollment

50 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Reduced flexibility in AROM of extension in the great toe
  • Pain that is worsened by walking and/or squatting
  • Impaired gait pattern

Exclusion criteria

  • Metatarsal stress fracture
  • Interdigital neuroma
  • Sesamoid pathology
  • Gout
  • Metatarsalgia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 2 patient groups

1
Experimental group
Description:
Immediate fitting with dynamic splinting following diagnosis of hallux limitus.
Treatment:
Device: Metatarsophalangeal Extension Dynasplint System
Other: Standard of Care
2
No Intervention group
Description:
Control arm; patients only treated with standard of care following diagnosis of hallux limitus.
Treatment:
Other: Standard of Care

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems